Intravenous immunoglobulin replacement therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Intravenous immunoglobulin replacement therapy, covering 2024-05-16 to 2024-05-16. Get the full timeline:
Most recent: Clinical Trial Update: Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell Impairment [Phase 2]